GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract HHSO100201700020CREGENERON PHARMACEUTICALS, INC.

Overview

Award facts

Net obligations
$278.84M
$278,844,172of $359.61M potential value
Outlays (paid to date)
$236.33M
$236.33M paid of $278.84M obligated$236,330,037
Period of performance
Sep 21, 2017 to Sep 25, 2027
Ends in 10 months
Modifications
17
Latest action Sep 16, 2026
Contract type
Definitive contract
PIID HHSO100201700020C

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD

Dates and value

Award date
Signed on Sep 21, 2017
Current value
$278,844,172Base and exercised options
Potential value (if all options are exercised)
$359,611,758

Obligations by fiscal year of action

  • FY2026: -$766,396 (de-obligation)
  • FY2025: -$331,708,160 (de-obligation)
  • FY2023: $326,475,498
  • FY2020: $246,597,124
  • FY2019: $19,552,893
  • FY2017: $18,693,213

Total across 6 fiscal years: $278,844,172

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 16, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationTARRYTOWN, NY
UEIN3F9MH7E6HD6
CAGE code544P9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationCorporation (not tax-exempt)Manufacturer of goods

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Administration For Strategic Preparedness And Response
  3. BARDA - ASPR / DAAPPO / BARDA DCMA
Funded from
Public health and social services emergency fundProgram activities075-0140Federal accounts (agency financial reports)

Place of performance

Place of performance
Tarrytown, Westchester County, New York 10591-6717
Congressional district (place of performance)
NY-17As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost sharingT
Offers received
1

Solicitation and notices

Solicitation ID
BAA16100SOL00002(as reported)

Contract details

Subcontracting plan
Plan not requiredB
Major program
Novel antibodies against influenza virus, emerging, re-emerging, and pre-emerging pathogens
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 21, 2017Base obligation at award: $18,693,213
Latest action
Sep 16, 2026 — Supplemental agreement (within scope)Modification P00017; obligation change -$766,396
Latest substantive action
Sep 16, 2026 — Supplemental agreement (within scope)Modification P00017; obligation change -$766,396
Latest funding action
Apr 29, 2020 — Funding onlyModification P00007; obligation change +$9,247,916; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Other administrative action7
  • Supplemental agreement (within scope)5
  • Change order4
  • Funding only1
18 actions recorded, Sep 21, 2017 to Sep 16, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$766,396
Latest action: change in base and all options
-$766,396

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7505
Contracting office code
75A501
Transactions recorded under this award key
18

Funding

Funding agency code
7500
Funding sub-tier code
7505
Funding office code
75A501
Treasury accounts
  • 075-2019/2020-0140-000
  • 075-2020/2021-0140-000
  • 075-2020/2024-0140-000
  • 075-X-0140-000
Object classes
  • 25.1: Advisory and assistance services
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • N: Emergency P.L. 116-136
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • V: Non-emergency P.L. 117-2
COVID-19 supplemental obligations
$142,753,157
COVID-19 supplemental outlays
$228,763,508